Seock-Ah Im
任锡雅
MD, PhD
Professor of Internal Medicine内科学教授
👥Biography 个人简介
Seock-Ah Im is a leading Korean breast cancer oncologist who has led multiple Asian and global clinical trials in HER2+ breast cancer. Her research addresses biological differences and the application of global treatment standards to Asian patient populations.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Asian HER2+ Breast Cancer Trials
Led Korean and Asian cooperative group trials of HER2-targeted agents, validating efficacy across Asian populations and informing regional treatment guidelines.
Pertuzumab in Asian Patients
Contributed to the Korean/Asian data informing pertuzumab approval and treatment guidelines in Korean practice.
Representative Works 代表性著作
A Phase III randomized study of adjuvant pertuzumab in patients with early HER2-positive breast cancer: APHINITY
NEJM (2017)
APHINITY trial including Asian patients.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 任锡雅 的研究动态
Follow Seock-Ah Im's research updates
留下邮箱，当我们发布与 Seock-Ah Im（Seoul National University Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment